Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats

Journal of Virology

Volumn 84, Issue 5, 2010, Pages 2236-2244

  Repic, Allison M ^a   Shi, Mingxia ^a   Scott, Rona S ^a   Sixbey, John W ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LATENT MEMBRANE PROTEIN 1;

ARTICLE; CELL CLONE; CONTROLLED STUDY; EPISOME; EPITHELIUM CELL; EPSTEIN BARR VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REINFECTION; VIRUS INFECTION; VIRUS REACTIVATION;

CELL LINE, TUMOR; EPITHELIAL CELLS; GENE DOSAGE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; PHENOTYPE; PLASMIDS; PROMOTER REGIONS, GENETIC; TERMINAL REPEAT SEQUENCES; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 77649209052     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01972-09     Document Type: Article

References (55)

1. Ali, A. K. M., S. Saito, S. Shibata, K. Takada, and T. Kanda. 1 July 2009. Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation. J. Virol. doi: 10.1128/JVI.01979-08.
2. Baer, R. J., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. F. Hatfill, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tuffnell, and B. C. Barrell. 1984. DNA sequences and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
3. Blackwood, E. M., and J. T. Kadonaga. 1998. Going the distance: a current review of enhancer action. Science 281:60-63.
4. Borza, C. M., and L. M. Hutt-Fletcher. 1998. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells. J. Virol. 72:7577-7582.
5. Brown, N. A., C.-R Liu, Y.-F. Wang, and C. R. Garcia. 1988. B-cell lympho-proliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus. J. Virol. 62:962-969.
6. Ceccarelli, S., V. Visco, S. Raffa, N. Wakisaka, J. S. Pagano, and M. R. Torrisi. 2007. Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int. J. Cancer. 121:1494-1506.
7. Chang, M.-H., C.-K. Ng, Y.-J. Lin, C.-L. Liang, P.-J. Chung, M.-L. Chen, Y.-S. Tyan, C.-Y. Hsu, C.-H. Shu, and Y.-S. Chang. 1997. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells. DNA Cell Biol. 16:829-837.
8. Chen, H., J. M. Lee, Y. Zong, M. Borowitz, M. H. Ng, R. F. Ambinder, and S. D. Hayward. 2001. Linkage between STAT regulation and Epstein-Barr virus gene expression. J. Virol. 75:2929-2937.
9. Clambey, E. T., H. W. Virgin IV, and S. H. Speck. 2000. Disruption of the murine gammaherpesvirus68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74:1973-1984.
10. Coffin, W. F., III, T. R. Geiger, and J. M. Martin. 2003. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contains a lipid raft targeting signal and plays a critical role in cytostasis. J. Virol. 77:3749-3758.
11. Cuomo, L., T. Ramquist, P. Trivedi, F. Wang, G. Klein, and M. G. Masucci. 1992. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line. Int. J. Cancer 51:949-955.
12. D'Aiuto, L. D., R. de Marco, E. Nwanegbo, A. Rizzo, J. R. Chaillet, A. Montecalvo, M. T. Lotze, and A. Gambotto. 2006. Evidence of the capability of the CMV enhancer to activate in trans gene expression in mammalian cells. DNA Cell Biol. 25:171-180.
13. Dawson, C. W., J. H. George, S. M. S. Blake, R. Longnecker, and L. S. Young. 2001. The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1. Virology 289:192-207.
14. Dukers, D. F., P. Meij, M. B. H. J. Vervoort, W. Vos, R. J. Scheper, C. J. L. M. Meijer, E. Bloemena, and J. M. Middeldorp. 2000. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunology 165:663-670.
15. Eliopoulos, A. G., C. W. Dawson, G. Mosialos, J. E. Floettmann, M. Rowe, R. J. Armitage, J. Dawson, J. M. Zapata, D. J. Kerr, M. J. Wakelam, J. C. Reed, E. Kieff, and L. S. Young. 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13:2243-2254.
16. Everly, D. N., Jr., B. A. Mainou, and N. Raab-Traub. 2004. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J. Virol. 78:13470-13478.
17. Fader, C. M., and M. I. Colombo. 2009. Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ. 16:70-78.
18. Fahraeus, R., L. Rymo, J. S. Rhim, and G. Klein. 1990. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449.
19. Flanagan, J., J. Middeldorp, and T. Sculley. 2003. Localization of the Epstein-Barr virus protein LMP1 to exosomes. J. Gen. Virology 84:1871-1879.
20. Floettmann, J. E., K. Ward, A. B. Rickinson, and M. Rowe. 1996. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223:29-40.
21. Gahn, T. A., and B. Sugden. 1995. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
22. Gilligan, K., H. Sato, P. Rajadurai, P. Busson, L. Young, A. Rickinson, T. Tursz, and N. Raab-Traub. 1990. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J. Virol. 64:4948-4956.
23. Gires, O., F. Kohlhuber, E. Kilger, M. Baumann, A. Kieser, C. Kaiser, R. Zeidler, B. Scheffer, M. Ueffing, and W. Hammerschmidt. 1999. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18:3064-3073.
24. Hammarskjöld, M. L., and M. C. Simurda. 1992. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J. Virol. 66:6496-6501.
25. Hammerschmidt, W., B. Sugden, and V. R. Baichwal. 1989. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63:2469-2475.
26. Henderson, A., S. Ripley, M. Heller, and E. Kieff. 1983. Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc. Natl. Acad. Sci. U. S. A. 80:1987-1991.
27. Hsiao, J. R., K. C. Chang, C. W. Chen, S. Y. Wu, I. J. Su, M. C. Hsu, Y. T. Jin, S. T. Tsai, K. Takada, and Y. Chang. 2009. Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma. Cancer Res. 69:4461-4467.
28. Johannsen, E., E. Koh, G. Mosialos, X. Tong, E. Kieff, and S. R. Grossman. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by Jκ and PU.1. J. Virol. 69:253-262.
29. Kaykas, A., and B. Sugden. 2000. The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene 19:1400-1410.
30. Keryer-Bibens, C., C. Pioche-Durieu, C. Villemant, S. Souquere, N. Nishi, M. Hirashima, J. Middeldorp, and P. Busson. 2006. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6:283-290.
31. Kieser, A., E. Kilger, O. Gires, M. Ueffing, W. Kolch, and W. Hammerschmidt. 1997. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16:6478-6485.
32. Kim, K.-R, T. Yoshizaki, H. Miyamori, K. Hasegawa, T. Horikawa, M. Furukawa, S. Harada, M. Seiki, and H. Sato. 2000. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19:1764-1771.
33. Lam, N., M. L. Sandberg, and B. Sugden. 2004. High physiological levels of LMP1 result in phosphorylation of eIF2α in Epstein-Barr virus-infected cells. J. Virol. 78:1657-1664.
34. Lee, D. Y., and B. Sugden. 2008. The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood 111:2280-2289.
35. Li, H. M., Z. H. Zhuang, Q. Wang, J. C. S. Pang, X. H. Wang, H. L. Wong, H. C. Feng, D. Y. Jin, M. T. Ling, Y. C. Wong, A. G. Eliopoulos, L. S. Young, D. P. Huang, and S. W. Tsao. 2004. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23:4488-4494.
36. Lo, A. K. F., D. P. Huang, K. W. Lo, Y. L. Chui, H. M. Li, J. C. S. Pang, and S.-W Tsao. 2004. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int. J. Cancer 109:919-925.
37. Lo, A. K. F., K. F. To, K. W. Lo, R. W. M. Lung, J. W. Y. Hui, G. Liao, and S. D. Hayward. 2007. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl. Acad. Sci. U. S. A. 104:16164-16169.
38. Lo, K. W., and D. P. Huang. 2002. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 12:451-462.
39. Longnecker, R., C. L. Miller, B. Tomkinson, X.-Q. Miao, and E. Kieff. 1993. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membranes 2A and 2B. J. Virol. 67:5068-5074.
40. Metzenberg, S. 1990. Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA1, EBNA2, or latent membrane protein. J. Virol. 64:437-444.
41. Moody, C. A., R. S. Scott, N. Amirghahari, C. A. Nathan, L. S. Young, C. W. Dawson, and J. W. Sixbey. 2005. Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A. J. Virol. 79:5499-5506.
42. Moody, C. A., R. S. Scott, T. Su, and J. W. Sixbey. 2003. Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J. Virol. 77:8555-8561.
43. Morris, M. A., C. W. Dawson, W. Wei, J. D. O'Neil, S. S. Stewart, J. Jia, A. I. Bell, L. S. Young, and J. R. Arrand. 2008. Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes. J. Gen. Virol. 89:2806-2820.
44. Ning, S., A. M. Hahn, L. E. Huye, and J. S. Pagano. 2003. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. J. Virol. 77:9359-9368.
45. Raab-Traub, N., and K. Flynn. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889.
46. Reisman, D., and B. Sugden. 1986. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846.
47. Sadler, R. H., and N. Raab-Traub. 1995. The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-less promoter within the first terminal repeat. J. Virol. 69:4577-4581.
48. Sato, H., T. Takimoto, S. Tanaka, J. Tanaka, and N. Raab-Traub. 1990. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J. Virol. 64:5295-5300.
49. Sjöblom, A., W. Yang, L. Palmqvist, A. Jansson, and L. Rymo. 1998. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter. J. Virol. 72:1365-1376.
50. Spain, T. A., R. Sun, and G. Miller. 1997. The locus of Epstein-Barr virus terminal repeat processing is bound with enhanced affinity by Sp1 and Sp3. Virology 237:137-147.
51. Speck, P., K. A. Kline, P. Cheresh, and R. Longnecker. 1999. Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J. Gen. Virol. 80:2193-2203.
52. Sternås, L., T. Middleton, and B. Sugden. 1990. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J. Virol. 64:2407-2410.
53. Stewart, S., C. W. Dawson, K. Takada, J. Curnow, C. A. Moody, J. W. Sixbey, and L. S. Young. 2004. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-κB transcription factor pathway. Proc. Natl. Acad. Sci. U. S. A. 101:15730-15735.
54. Tsai, C.-N., C.-M. Lee, C.-K. Chien, S.-C. Kuo, and Y.-S. Chang. 1999. Additive effect of Sp1 and Sp3 in regulation of the ED-L1E promoter of the EBV LMP1 gene in human epithelial cells. Virology 261:288-294.
55. Xue, S.-A., M. D. Jones, Q.-L. Lu, J. M. Middeldorp, and B. E. Griffin. 2003. Genetic diversity: frameshift mutations alter coding of a gene (Epstein-Barr virus LF3 gene) that contains multiple 102-base-pair direct sequence repeats. Mol. Cell. Biol. 23:2192-2201.